On 4 April, 84,000 doses of AstraZeneca vaccines against COVID-19 arrived in Azerbaijan as part of the COVAX initiative, which is supported by the EU.
“EU contributions made the development and production of these vaccines and their delivery to Azerbaijan possible today,” said the Head of the EU Delegation to Azerbaijan Kestutis Jankauskas at the airport to welcome the shipment. “AstraZeneca is a safe and effective vaccine approved by the European Medicine Agency…Thanks to COVAX and Team Europe, people in Azerbaijan will now have a choice of vaccines. We encourage people to get vaccinated! This is the best way to beat COVID!”
Azerbaijan plans to import 432,000 doses of the AstraZeneca vaccine by late May and 218,790 doses of the Pfizer-BioNTech vaccine within eight weeks.
The European Union is one of the biggest supporters of COVAX, a global collaboration to accelerate the development, production, and equitable access to COVID-19 vaccines. The EU’s Team Europe (which combines resources from the EU, its Member States and European financial institutions) supports COVAX with more than €2.2 billion, including €1 billion from the EU budget.
Find out more
Interested in the latest news and opportunities?
This website is managed by the EU-funded Regional Communication Programme for the Eastern Neighbourhood ('EU NEIGHBOURS east’), which complements and supports the communication of the Delegations of the European Union in the Eastern partner countries, and works under the guidance of the European Commission’s Directorate-General for Neighbourhood Policy and Enlargement Negotiations, and the European External Action Service. EU NEIGHBOURS east is implemented by a B&S Europe-led consortium. It is part of the larger Neighbourhood Communication Programme (2020-2024) for the EU's Eastern and Southern Neighbourhood, which also includes 'EU NEIGHBOURS south’ project that runs the EU Neighbours portal.
The information on this site is subject to a Disclaimer and Protection of personal data. © European Union,